Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1952-1956

  Ulferts, Rachel ^a   Van Der Linden, Lonneke ^b,c   Thibaut, Hendrik Jan ^c   Lanke, Kjerstin H W ^b   Leyssen, Pieter ^c   Coutard, Bruno ^d   De Palma, Armando M ^c   Canard, Bruno ^d   Neyts, Johan ^c   Van Kuppeveld, Frank J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PROTEIN VP2; UNCLASSIFIED DRUG; VIRUS PROTEIN 2C; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENTEROVIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; RHINOVIRUS; RNA REPLICATION; VIRUS REPLICATION;

CARRIER PROTEINS; ENTEROVIRUS B, HUMAN; ENTEROVIRUS D, HUMAN; FLUOXETINE; SEROTONIN UPTAKE INHIBITORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84875162616     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02084-12     Document Type: Article

References (29)

1. Lanke KHW, van der Schaar HM, Belov GA, Feng Q, Duijsings D, Jackson CL, Ehrenfeld E, van Kuppeveld FJM. 2009. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J. Virol. 83:11940 -11949.
2. Zuo J, Quinn KK, Kye S, Cooper P, Damoiseaux R, Krogstad P. 2012. Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob. Agents Chemother. 56:4838-4844.
3. de Palma AM, Heggermont W, Leyssen P, Pürstinger G, Wimmer E, Clercq ED, Rao A, Monforte AM, Chimirri A, Neyts J. 2007. Antienterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles. Biochem. Biophys. Res. Commun. 353:628-632.
4. Reed L, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27:493- 497.
5. Wessels E, Duijsings D, Notebaart RA, Melchers WJG, van Kuppeveld FJM. 2005. A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-Golgi transport. J. Virol. 79:5163-5173.
6. De Palma AM, Heggermont W, Lanke K, Coutard B, Bergmann M, Monforte AM, Canard B, De Clercq E, Chimirri A, Pürstinger G, Rohayem J, van Kuppeveld F, Neyts J. 2008. The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C. J. Virol. 82:4720-4730.
7. Hsu N-Y, Ilnytska O, Belov G, Santiana M, Chen Y-H, Takvorian PM, Pau C, van der Schaar H, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, van Kuppeveld FJM, Altan-Bonnet N. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799-811.
8. Banerjee R, Dasgupta A. 2001. Interaction of picornavirus 2C polypeptide with the viral negative-strand RNA. J. Gen. Virol. 82:2621-2627.
9. Echeverri A, Banerjee R, Dasgupta A. 1998. Amino-terminal region of poliovirus 2C protein is sufficient for membrane binding. Virus Res. 54: 217-223.
10. Echeverri AC, Dasgupta A. 1995. Amino terminal regions of poliovirus 2C protein mediate membrane binding. Virology 208:540 -553.
11. Rodríguez PL, Carrasco L. 1995. Poliovirus protein 2C contains two regions involved in RNA binding activity. J. Biol. Chem. 270:10105-10112.
12. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E. 1997. Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J. Virol. 71:8962- 8972.
13. Banerjee R, Weidman MK, Echeverri A, Kundu P, Dasgupta A. 2004. Regulation of poliovirus 3C protease by the 2C polypeptide. J. Virol. 78: 9243-9256.
14. Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, Jiang P. 2010. Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog. 6:e1001066. doi:10.1371/journal.ppat.1001066.
15. Tang W-F, Yang S-Y, Wu B-W, Jheng J-R, Chen Y-L, Shih C-H, Lin K-H, Lai H-C, Tang P, Horng J-T. 2007. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J. Biol. Chem. 282: 5888-5898.
16. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Rinaudo MS, Ehrenfeld E. 2006. Testing the modularity of the N-terminal amphipathic helix conserved in picornavirus 2C proteins and hepatitisCNS5A protein. Virology 344:453- 467.
17. Yin J, Liu Y, Wimmer E, Paul AV. 2007. Complete protein linkage map between the P2 and P3 non-structural proteins of poliovirus. J. Gen. Virol. 88:2259 -2267.
18. Cho MW, Teterina N, Egger D, Bienz K, Ehrenfeld E. 1994. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202:129 -145.
19. Vance LM, Moscufo N, Chow M, Heinz BA. 1997. Poliovirus 2C region functions during encapsidation of viral RNA. J. Virol. 71:8759-8765.
20. Wang C, Jiang P, Sand C, Paul AV, Wimmer E. 2012. Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/ 2CATPase interactions are essential for morphogenesis. J. Virol. 86:9964-9975.
21. Gorbalenya AE, Koonin EV, Wolf YI. 1990. A new superfamily of putative NTP-binding domains encoded by genomes of small DNA and RNA viruses. FEBS Lett. 262:145-148.
22. Adams P, Kandiah E, Effantin G, Steven AC, Ehrenfeld E. 2009. Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. J. Biol. Chem. 284:22012-22021.
23. Klein M, Hadaschik D, Zimmermann H, Eggers HJ, Nelsen-Salz B. 2000. The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: the significance of viral protein 2C. J. Gen. Virol. 81:895-901.
24. Mirzayan C, Wimmer E. 1994. Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity. Virology 199:176 -187.
25. Pfister T, Wimmer E. 1999. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J. Biol. Chem. 274:6992-7001.
26. Rodríguez PL, Carrasco L. 1993. Poliovirus protein 2C has ATPase and GTPase activities. J. Biol. Chem. 268:8105- 8110.
27. Sweeney TR, Cisnetto V, Bose D, Bailey M, Wilson JR, Zhang X, Belsham GJ, Curry S. 2010. Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism. J. Biol. Chem. 285:24347-24359.
28. Lantez V, Dalle K, Charrel R, Baronti C, Canard B, Coutard B. 2011. Comparative production analysis of three phlebovirus nucleoproteins under denaturing or non-denaturing conditions for crystallographic studies. PLoS Negl Trop. Dis. 5:e936. doi:10.1371/journal.pntd.0000936.
29. LLerena A, Dorado P, Berecz R, González A, Jesús Norberto M, De la Rubia A, Cáceres M. 2003. Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 783:25-31.